AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2024
Sep 4, 2024
30016_dirs_2024-09-04_154022cc-20f2-4cbc-95c0-861830e38858.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-09-01
Reporting Person: Schreck Michael (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-01 | Common Stock | M | 164 | — | Acquired | 961 | Direct |
| 2024-09-01 | Common Stock | F | 48 | $481.33 | Disposed | 913 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-01 | Restricted Stock Unit | $ | M | 164 | Disposed | Common Stock (164) | Direct |
Footnotes
F1: Includes 11 shares purchased under the Issuer's Employee Stock Purchase Plan June 28, 2024.
F2: Closing price of Issuer common stock on August 30, 2024.
F3: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments beginning on September 1, 2021.
F4: Not applicable.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26